NorthWest Biotherapeutics Inc (NWBO)

[ae kusterer]

FE Mike:With
your good relationship with Dave Innes, perhaps you might be able to get an inkling as to whether Linda Liau will be able to present on the NWBO scientific publication at this conference, 10/17?





Linda Liau speaks 10/17 at 12/45 p.m. at CNS. Is she booked for any other presentations in September, October, or Novemebr, '21?



https://2021meeting.cns.org/Assets/edccc356-3f88-4c09-ba3f-b101e0a28585/637636915731000000/cns21787-21am-prelim-05242021-copy-with-4-new-gss-pages-080421-3-pm-pdf?inline=ture



NEW! 12:45–4:15 pm
SYM20B: Immunotherapy for Brain Tumors: New
Concepts
Course Directors: E. Antonio Chiocca, Linda M. Liau
Faculty: Nduka M. Amankulor, William T. Curry, Peter E.
Fecci, Amy B. Heimberger, Michael Lim, Edjah K. Nduom,
Hideho Okada, Ian F. Parney
Course Description: This symposium will provide a brief
overview of relevant immunological principles and define
discrete immune pathways regulating the initiation and
progression of malignant brain tumors. More importantly,
cutting-edge immunotherapeutic approaches for the
treatment of CNS tumors will be defined.
Learning Objectives:
? Evaluate various immune pathways that contribute to the
formation and progression of CNS malignancies
? Compare different immunotherapeutic strategies,
including virotherapy, adoptive cellular immunotherapy,
and immune checkpoint inhibition
? Compare neoadjuvant and adjuvant immunotherapy